Stockreport

Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF -- Results consistent with Phase 3 LAVENDER™ and open-label LILAC™ studies SAN DIEGO, March 05, 2025 BUSINESS WIRE )--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today [Read more]